X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2024 Earnings Call Transcript March 25, 2025
X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.17.
Operator: Greetings, and welcome to the X4 Pharmaceuticals Fourth Quarter and Full Year 2024 Financial and Operating Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. And it is now my pleasure to turn to your host, Dan Ferry from LifeSci...
